MyFinsight
Home
About
Contact
ebs: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, EBS has $1,461,000K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
1,461,000
1,417,100
Total stockholders equity
582,500
536,200
Total liabilities and stockholders equity
1,461,000
1,417,100
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Assets held for sale
$6,300K
Prepaid expenses and
other current assets
$25,600K
Inventories, net
$356,300K
Accounts receivable, net
$149,500K
Restricted cash
$3,700K
Cash and cash
equivalents
$245,500K
Other assets
$11,600K
Intangible assets, net
$452,700K
Property, plant and
equipment, net
$209,800K
Total current assets
$786,900K
Total assets
$1,461,000K
Total liabilities and
stockholders equity
$1,461,000K
Total stockholders
equity
$582,500K
Total liabilities
$878,500K
Accumulated deficit
-$105,200K
Accumulated other
comprehensive loss, net
-$7,500K
Treasury stock, at cost,
7.9 and 5.6 common...
$243,500K
Additional paid-in capital
$938,600K
Other liabilities
$42,600K
Deferred tax liability
$36,300K
Debt
$663,100K
Total current
liabilities
$136,500K
Common stock, 0.001 par
value per share 200.0...
$100K
Liabilities held for sale
$4,500K
Other current
liabilities
$24,100K
Accrued compensation
$36,600K
Accrued expenses
$13,900K
Accounts payable
$57,400K
Subscribe for Financial Insights
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)